Mutations in LRRK2 are a common cause of genetic Parkinson's disease (PD). LRRK2 is a multi-domain Roco protein, harbouring kinase and GTPase activity. In analogy with a bacterial homologue, LRRK2 was proposed to act as a GTPase activated by dimerization (GAD), while recent reports suggest LRRK2 to exist under a monomeric and dimeric form in vivo. It is however unknown how LRRK2 oligomerization is regulated. Here, we show that oligomerization of a homologous bacterial Roco protein depends on the nucleotide load. The protein is mainly dimeric in the nucleotide-free and GDP-bound states, while it forms monomers upon GTP binding, leading to a monomer-dimer cycle during GTP hydrolysis. An analogue of a PD-associated mutation stabilizes the dimer and decreases the GTPase activity. This work thus provides insights into the conformational cycle of Roco proteins and suggests a link between oligomerization and disease-associated mutations in LRRK2.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5714945PMC
http://dx.doi.org/10.1038/s41467-017-01103-4DOI Listing

Publication Analysis

Top Keywords

mutations lrrk2
8
roco protein
8
gtpase activity
8
lrrk2
7
homologue parkinson's
4
parkinson's disease-associated
4
protein
4
disease-associated protein
4
protein lrrk2
4
lrrk2 undergoes
4

Similar Publications

Mutations that increase LRRK2 kinase activity have been linked to Parkinson's disease and Crohn's disease. LRRK2 is also activated by lysosome damage. However, the endogenous cellular mechanisms that control LRRK2 kinase activity are not well understood.

View Article and Find Full Text PDF

Mutations in leucine-rich repeat kinase 2 () are the most common cause of familial and sporadic Parkinson's disease (PD). While the clinical features of -PD patients resemble those of typical PD, there are significant differences in the pathological findings. The pathological hallmark of definite PD is the presence of α-synuclein (αSYN)-positive Lewy-related pathology; however, approximately half of -PD cases do not have Lewy-related pathology.

View Article and Find Full Text PDF
Article Synopsis
  • This review focuses on genetic mutations in kinases related to Parkinson's Disease and analyzes both existing treatments and potential new therapeutic targets.
  • The study highlights four key kinases—PINK1, LRRK2, GAK, and PRKRA—emphasizing that LRRK2 has the most marketed inhibitors, while PINK1, GAK, and PRKRA remain largely unexplored.
  • It calls for increased research on these underinvestigated kinases to develop new therapies that could improve treatment options and address the progression of Parkinson's Disease.
View Article and Find Full Text PDF

Loss of LRRK2 activity induces cytoskeleton defects and oxidative stress during porcine oocyte maturation.

Cell Commun Signal

January 2025

Key Laboratory of Research on Clinical Molecular Diagnosis for High Incidence Diseases in Western Guangxi of Guangxi Higher Education Institutions, Reproductive Medicine of Guangxi Medical and Health Key Discipline Construction Project, Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, China.

Leucine-rich repeat kinase 2 (LRRK2) is a ROCO family member which its mutation is closely related with Parkinson's disease, and LRRK2 is widely involved into the regulation of autophagy, vesicle transport and neuronal proliferation. However, the roles of LRRK2 during mammalian oocyte maturation are still largely unclear. In present study, we disturbed the activity of LRRK2 and showed its essential roles in porcine oocytes.

View Article and Find Full Text PDF

Background: Extracellular vesicles are easily accessible in various biofluids and allow the assessment of disease-related changes in the proteome. This has made them a promising target for biomarker studies, especially in the field of neurodegeneration where access to diseased tissue is very limited. Genetic variants in the LRRK2 gene have been linked to both familial and sporadic forms of Parkinson's disease.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!